ea0049ep1010 | Pituitary - Clinical | ECE2017
Vila Greisa
, Jan vanderLely Arrt
, Neggers Sebastian
, Luger Anton
, Webb Susan
, Biller Beverly
, Jonsson Peter
, Hey-Hadavi Judith
Introduction: Hypertension (HTN) is a major cardiovascular (CV) risk factor and independent predictor of the increased mortality in patients with acromegaly. Surgical cure of acromegaly is associated with improvement in blood pressure (BP) levels, however little is known on the effect of pegvisomant (PEGV) treatment on HTN.Methods/design: ACROSTUDY is an open-label, international, prospective, non-interventional study monitoring the long-term safety of P...